NexImmune, Inc.

Professional Services 📍 Gaithersburg, United States 👥 11-50 employees 💰 $162.9M raised 📅 Founded 2011

NexImmune is a publicly traded, clinical stage biotechnology company developing unique approaches to T cell immunotherapies based on its propriety Artificial Immune Modulation (AIM™) technology. NexImmune has a differentiated platform and pipeline of product candidates in pre-clinical and phase 1/2 stages with lead pr

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Professional Services

Country

United States

Employees

11-50

Est. Revenue

$2.2B

Founded

2011

Cloud

Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	🔒 Subscribers only
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$90K – $225K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	Google Analytics
CMS / Platform	WordPress
Frontend Stack	🔒 Subscribers only

Detected from NexImmune, Inc.'s public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Professional Services), similar size

ADVANCED DISPOSAL SERVICE

11-50 ☁️ Unknown

Integrity Marketing Group Inc

1-10 ☁️ AWS

1-10 ☁️ AWS

Data detected 2026-06-13 · Methodology · Suggest a correction